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Psychoses and their treatments: a dual threat for the patients' total 
health?
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The primary objective of treating any illness is to mini-
mize the effects of the illness on the patient's life, thereby
enabling the individual to lead the highest achievable
quality of life. Schizophrenia is a chronic disorder with
devastating effects on several aspects of the patient's life
and is associated with a shortened lifespan (age-standard-
ized mortality twice that of the general population), a
high risk of suicide (5–10% of patients die from suicide)
and significant impairment in function (only about 10%
of patients are fully employed and live independently).
The broad objective of treatment is to reduce the overall
morbidity and mortality of the disorder by decreasing the
frequency and severity of episodes of psychotic exacerba-
tion and improving the functional capacity and quality of
lives of the individuals afflicted with the illness. Whereas
antipsychotic medications are useful in reducing many
manifestations of the illness, their adverse effects can
adversely impact the morbidity and mortality of the ill-
ness. Whereas second-generation antipsychotics demon-
strate a broader spectrum of efficacy than first-generation
agents and have a lower propensity to cause neurological
side-effects, they are associated with varying degrees of
metabolic side-effects that substantially increase the risk
of ischemic heart disease (the single-largest cause of death
in schizophrenia). While available second-generation
antipsychotics are broadly similar in terms of their effi-
cacy, they vary significantly with regards to their side-
effect profiles. In this presentation, a model of conceptu-
alizing the impact of treatment on the lives of individuals
suffering from schizophrenia will be presented and antip-
sychotic treatment approaches that maximize effective-
ness for each individual patient summarized.
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